Ya-Ting Han l Medicine and Dentistry l Best Researcher Award

Posted on by ScienceFather

Dr. Ya-Ting Han l Medicine and Dentistry l Best Researcher Award

Lecturer at Tianjin Medical University, China

Ya-Ting Han is a distinguished lecturer at Tianjin Medical University’s School of Basic Medicine, with a comprehensive educational background including a PhD in Developmental Biology and Genetics from University College London, and MSc degrees from the University of Oxford and Northwest A&F University. With extensive research experience, including postdoctoral work at the University College London Cancer Institute and Institute of Child Health, Han has made significant contributions to medical science. Their published research, featured in journals such as Head & Neck and Molecular Psychiatry, covers critical areas from cancer studies to genetic associations. Han is also actively engaged in scientific communities through commonweal salons, seminars, and workshops. Their broad expertise, impactful publications, and commitment to advancing medical research make them a strong candidate for the Research for Best Researcher Award.

Profile:

Education

Ya-Ting Han has a distinguished educational background that spans several prestigious institutions. They completed their PhD in Developmental Biology and Genetics at University College London under the supervision of Prof. Jane Sowden. Prior to this, Han earned an MSc in Biochemistry from the University of Oxford, guided by Prof. Louis Mahadevan. Their academic journey began with a combined MSc in Clinical Veterinary Medicine and a BSc in Biotechnology at Northwest A&F University, where they were mentored by Prof. Dou Zhongying. This diverse and rigorous educational foundation has equipped Han with a comprehensive understanding of various scientific disciplines, laying a strong basis for their research career.

Professional Experience

Ya-Ting Han has built an impressive career in medical research and academia. Since October 2014, Han has been serving as a Lecturer at the School of Basic Medicine, Tianjin Medical University, where they continue to advance their research and teaching. Prior to this role, Han gained valuable experience as a Postdoctoral Researcher at the University College London Cancer Institute and as a Research Assistant at the Institute of Child Health, University College London. Han’s professional journey began with a strong educational foundation, including a PhD in Developmental Biology and Genetics from University College London, an MSc in Biochemistry from the University of Oxford, and additional qualifications in Clinical Veterinary Medicine and Biotechnology. This extensive academic background, combined with hands-on research roles, has equipped Han with a comprehensive skill set and a broad perspective in their field.

Research Interest

Ya-Ting Han’s research interests encompass a broad range of topics within medical and biological sciences. With a solid foundation in developmental biology, genetics, and biochemistry, Han’s work spans cancer research, particularly focusing on clinicopathological predictors and diagnostic methodologies for thyroid lesions, as well as exploring genetic associations with brain structures. Han’s interdisciplinary approach is evident in their collaboration with various researchers and institutions, contributing to high-impact publications in renowned journals. Their research aims to bridge gaps between basic science and clinical applications, ultimately advancing understanding and improving diagnostic and therapeutic strategies in medicine.

Research Skills

Ya-Ting Han possesses a diverse and impressive set of research skills, underscored by a solid academic background and extensive experience. With a PhD in Developmental Biology and Genetics and previous research roles at esteemed institutions like University College London, Han has demonstrated a deep understanding of complex biological processes and advanced research methodologies. Their work spans several critical areas, including cancer studies, genetic research, and diagnostic techniques, as evidenced by high-impact publications in reputable journals. Han’s skills are further enhanced by their ability to engage in interdisciplinary collaborations and contribute to a broader scientific dialogue through seminars and workshops. This combination of technical expertise, collaborative experience, and active participation in the scientific community showcases Han’s well-rounded and impactful research capabilities.

Award and Recognition

Ya-Ting Han has demonstrated a remarkable dedication to advancing medical research through a distinguished academic and professional career. Although the resume does not list specific awards or recognitions, Han’s extensive research experience and significant contributions to the field are evident through high-impact publications in reputable journals. Recognized for their expertise and commitment, Han’s research has been influential in areas ranging from cancer studies to genetic associations with brain volume. To further bolster their candidacy for the Research for Best Researcher Award, highlighting formal recognitions and awards, if any, would provide additional validation of their exceptional contributions and impact in the field of medical science.

Conclusion

Ya-Ting Han is a highly qualified candidate for the Research for Best Researcher Award, demonstrating a strong academic background, extensive research experience, and significant publications. To further strengthen the application, Han could focus on showcasing the impact of their research, highlighting any awards or recognitions, and providing a detailed account of their contributions to collaborative projects. Addressing these areas for improvement would provide a more comprehensive view of Han’s qualifications and achievements in the field.

Publication Top Notes

  • Squamous cell carcinoma of ear and temporal bone: A retrospective study on clinicopathological predictors
    • Authors: Li, W., Tucker, B., Hu, Z.-D., Zhang, M.-F., Han, Y.-T.
    • Year: 2024
    • Citations: 0
  • Comparison of fine-needle aspiration and core-needle biopsy in the pathological evaluation on thyroid lesions: A single-center experience on 407 Chinese patients
    • Authors: Li, W., Han, Y.-T., Hu, Z., Cai, W., Zhang, M.
    • Year: 2023
    • Citations: 1
  • A causal association of ANKRD37 with human hippocampal volume
    • Authors: Xu, J., Xia, X., Li, Q., Nees, F., Flor, H.
    • Year: 2022
    • Citations: 3
  • Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57CDKN1C and TP53INP1 in mantle cell lymphoma
    • Authors: Li, W., Bi, C., Han, Y., Wang, X., Fu, K.
    • Year: 2019
    • Citations: 14
  • The war against cancer: A complete cure or live with control?
    • Authors: Han, Y., Wang, X.
    • Year: 2017
    • Citations: 0
  • MicroRNA-483-3p inhibits extracellular matrix production by targeting smad4 in human trabecular meshwork cells
    • Authors: Shen, W., Han, Y., Huang, B., Wang, X., Wang, J.
    • Year: 2015
    • Citations: 34

 

Mariano Marrodan | Medicine and Dentistry | Young Scientist Award

Posted on by ScienceFather

Dr. Mariano Marrodan | Medicine and Dentistry | Young Scientist Award

Surgery Resident and Fleni, Argentina.

Dr. Mariano Marrodan, MD, MSc, is a distinguished neurologist based in Buenos Aires, Argentina, with a robust background in neuroimmunology and multiple sclerosis. Currently, he serves as a Staff Neurologist at Fleni and Hospital Zonal General de Agudos Domingo Mercante. Dr. Marrodan holds a Master’s in Neuroimmunology from Universidad Autónoma de Barcelona and has completed notable fellowships at Cemcat and FLENI. His clinical research focuses on multiple sclerosis, autoimmune encephalitis, and neuroimmunology, with significant contributions to the understanding of Susac Syndrome and neuromyelitis optica spectrum disorders. He has published extensively in prestigious journals and is actively involved in mentoring and teaching, including directing neuroimmunology courses and coordinating virtual neuroimmunology rounds. Dr. Marrodan’s work, recognized through various awards, showcases his impact on advancing neurological research and improving patient care in Argentina and beyond.

Profile

Education

Dr. Mariano Marrodan’s educational background is distinguished by rigorous training and specialization in neurology and neuroimmunology. He earned his medical degree from Austral University in Buenos Aires, Argentina, graduating with honors in 2014. Following this, Dr. Marrodan completed his Neurology Residency at the Institute for Neurological Research Raul Carrea – FLENI from 2014 to 2018. His pursuit of specialized knowledge led him to a Clinical Fellowship in Multiple Sclerosis and Neuroimmunology at FLENI, which he completed in 2021. To further deepen his expertise, he pursued a Master’s in Neuroimmunology at the Universidad Autónoma de Barcelona (UAB), Spain, from 2022 to 2023. Additionally, he undertook a Multiple Sclerosis Research Fellowship at the Centre d’Esclerosi Múltiple de Catalunya (Cemcat) in Barcelona during the first half of 2023, augmenting his skills in advanced neuroimmunological research.

Professional Experience

Dr. Mariano Marrodan is a distinguished neurologist with extensive professional experience in both clinical and academic settings. Currently, he serves as a Staff Neurologist at Fleni in Buenos Aires, where he is involved in general neurology and the division of Multiple Sclerosis and Neuroimmunology. His role at Fleni began in June 2021 and includes contributions to inpatient services and specialized neuroimmunology care. Additionally, Dr. Marrodan works at Hospital Zonal General de Agudos Domingo Mercante and has held various roles at Fleni, including Junior Attending and Emergency Department Neurologist. His prior experience includes serving as a Staff Neurologist at the neurological rehabilitation center “La Horqueta” and as Neurology Chief Resident at FLENI. Dr. Marrodan’s background reflects a strong commitment to advancing neurology through clinical practice, research, and education.

Research Interests

Dr. Mariano Marrodan’s research focuses on advancing our understanding of neuroimmunological and neurodegenerative diseases, particularly Multiple Sclerosis (MS) and related conditions. His work emphasizes the pathophysiology, diagnostic strategies, and treatment outcomes of MS and neuromyelitis optica spectrum disorders (NMOSD). Dr. Marrodan is particularly interested in exploring the impact of novel therapeutic approaches and assessing their efficacy in real-world settings. His research involves extensive clinical and observational studies, such as evaluating the effects of oral Cladribine on MRI lesions in MS patients and developing a Latin-American database for Susac Syndrome. He is also engaged in the International MS Microbiome Study and the Argentinean Multiple Sclerosis Registry, which aim to deepen the understanding of disease mechanisms and treatment responses. Through his innovative research, Dr. Marrodan seeks to improve patient care and contribute to the global knowledge base on neuroimmunological disorders.

Research Skills

Dr. Mariano Marrodan exhibits exceptional research skills across multiple dimensions of neurology. His expertise spans clinical and basic research, with a notable focus on multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), and autoimmune encephalitis. Dr. Marrodan excels in designing and conducting observational and interventional studies, such as his principal investigator role in studies on oral Cladribine and Susac Syndrome. His proficiency extends to statistical analysis and study design, evidenced by his involvement in large-scale registries and multicentric collaborations. Dr. Marrodan’s adeptness in using advanced diagnostic tools, including MRI and immunological assessments, complements his strong publication record in high-impact journals. His leadership in coordinating neuroimmunology courses and mentoring junior researchers further underscores his commitment to advancing knowledge and fostering scientific growth. Dr. Marrodan’s multifaceted research skills make him a distinguished contributor to the field of neurology.

Awards and Recognition 🏆

Dr. Marrodan has received recognition through his roles in prestigious research projects and his contributions to significant publications. His continued involvement in high-profile academic and clinical roles indicates a respected position within his field.

Conclusion 🏅

Dr. Mariano Marrodan’s extensive research contributions, collaborative efforts, and applied clinical research make him a compelling candidate for the Best Researcher Award. His work not only advances the field of neurology but also impacts clinical practice and patient outcomes on a regional and global scale.

Publications Top Notes

  • Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM)
    • Authors: Carnero Contentti, E., Lopez, P.A., Patrucco, L., Alonso Serena, M., Rojas, J.I.
    • Year: 2024
  • Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study
    • Authors: Carnero Contentti, E., Lopez, P.A., Pettinicchi, J.P., Caride, A., Rojas, J.I.
    • Year: 2024
  • Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings
    • Authors: Pestchanker, C., Bertado Cortez, B., Lana Peixoto, M.A., Lopez, P., Carnero Contentti, E.
    • Year: 2024
  • Selection of disease modifying therapies in multiple sclerosis based on patient’s age and disease activity: Data from a nationwide registry
    • Authors: Piedrabuena, M.A., Correale, J., Fiol, M., Martinez, C.M., Ysrraelit, M.C.
    • Year: 2024
  • Clinical impact of gender and age at onset on disease trajectory in primary progressive multiple sclerosis patients
    • Authors: Camerlingo, S., Rubinstein, F., Celia Ysrraelit, M., Silva, B.A., Alonso, R.
    • Year: 2024
    • Citations: 1
  • Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina
    • Authors: Carnero Contentti, E., López, P.A., Pappolla, A., Alonso Serena, M., Rojas, J.I.
    • Year: 2024
    • Citations: 1
  • Diagnostic MRI Score to Differentiate Susac Syndrome from Primary Angiitis of the Central Nervous System and Multiple Sclerosis
    • Authors: Marrodan, M., Calandri, I.L., Bocancea, D.I., Fiol, M.P., Correale, J.
    • Year: 2024
  • Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry
    • Authors: Carnero Contentti, E., Lopez, P.A., Pettinicchi, J.P., Paul, F., Rojas, J.I.
    • Year: 2023
    • Citations: 4
  • Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome
    • Authors: Plantone, D., Sabatelli, E., Locci, S., De Stefano, N., Iorio, R.
    • Year: 2023
    • Citations: 2
  • Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting
    • Authors: Carnero Contentti, E., Lopez, P.A., Tkachuk, V., Paul, F., Rojas, J.I.
    • Year: 2023
    • Citations: 3